Navigation Links
Alzheimer's Treatment Clinical Trial Receives Clearance
Date:5/1/2013

(PRWEB) May 01, 2013

Neurological Recovery Guide and Neurological Wellness Center have been facilitating recovery from Alzheimer's disease since 2010. Although the precise causes of Alzheimer's Disease are still unknown, there is a growing body of evidence linking chronic inflammatory events in the brain with the onset and progression of AD. Etanercept (Enbrel) is a drug approved to treat the acute inflammatory processes involved in certain forms of arthritis and psoriasis. This Alzheimer's clinical trial is designed to confirm the findings of Dr. Tobinick who pioneered a means of circumventing the blood brain barrier by administering Enbrel to the back of the neck in a prescribed manner referred to as a perispinal injection. This study will be conducted at the research office of Neurological Wellness Center with individuals who have been diagnosed with mild to moderate AD. In addition to perispinally administered etanercept, study participants will be given minocycline, n-acetylcysteine, turmeric, and fish oil. This open label crossover pilot study will evaluate the effect of treatment over a six week period. Assessment tools will include the Mini-mental Status Exam (MMSE), the Oxford Happiness Questionnaire and the Alzheimer's Disease Assessment Scale cognitive sub-scale (ADAS-cog).

Perispinal injections are simple subcutaneous injections, performed with a fine gauge ½ inch needle, administered to the soft fatty tissue in the back of the neck. Neurological Wellness Center offers a complete two-hour course on Alzheimer's treatment, stroke treatment and traumatic brain injury treatment covering all aspects of perispinal injection technique at their center in Managua Nicaragua.

For many, flying to Neurological Wellness Center in Managua Nicaragua to receive this personalized training is an enormous expense and inconvenience. To overcome this problem, Neurological Wellness Center, under the direction of Augusto Ramirez, M.D., created Perispinal Enbrel Step-By-Step Instructional Video and accompanying e-book. This 24-minute video and 37-page e-book are now available online at http://www.neurological-recovery-guide.com.

Augusto Ramirez, M.D., Director of Neurological Wellness Center, a private medical group in Managua Nicaragua, authorized this press release.

The drug Enbrel is available now. Enbrel received FDA approval in 1998. Its safety profile is well understood. For Enbrel to effectively treat Alzheimer’s, stroke and TBI, it must be administered to the back of the neck precisely between the cervical vertebrae C-5 and C-6. This perispinal injection allows Enbrel to enter the brain by lymph drainage assisted by gravity. Fortunately for the millions of people now afflicted with Alzheimer’s, stroke and TBI, a video is now available online detailing in step-by-step fashion how to administer a perispinal injection of Enbrel,” said Dr. Rolando Rodrigues a neurosurgeon with Neurological Wellness Center.

To enroll in a hands-on instructional course on perispinal injections visit: reversealzheimersnow.com.

To purchase an instructional video and e-book on administering perispinal injections visit: neurological-recovery-guide.com.

To purchase Enbrel at the lowest prices in North America visit: genuine-enbrel-cheaper.com/.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10603523.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Neurological Wellness Center's Novel Neuro-Inflammation Inhibition Procedure that Induces Rapid Recovery from Alzheimer's, Stroke and Brain Injury is Now Being Taught in a Newly Released Video
2. A Feinstein Institute for Medical Research Study Shows Early Cognitive Problems among Those Who Eventually Get Alzheimer's
3. Goldberg & Goldberg Files Wrongful Death Lawsuit on Behalf of a 91 year-old Alzheimer's Patient Who Froze to Death Outside a Retirement Community
4. Watson, IBM'S Supercomputer is Now Programmed to Recommend Perispinally Administered Etanercept as an Alzheimer's Disease Treatment
5. Congresswoman Michelle Bachmann Supports Barak Obama's Call to Prioritize Research to "Unlock the Answers to Alzheimer's"
6. Life Extension Foundation Seeks Volunteers with Alzheimer's to Participate in a Clinical Trial Utilizing a Common Arthritis Drug
7. New Study Links Air Pollution to Alzheimer’s Disease -- Says Cure Alzheimer's Fund
8. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
9. Clinical insight improves treatment with new lung cancer drug
10. Rapid Asthma Treatment in ER May Prevent Admission
11. Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills ... specialty vendors and unique items from across the nation, this holiday-themed event will raise ... offered by the VNA. The boutique will be open Saturday, November 4 (10:00 ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... CAESAREA, Israel and NEW YORK , Sept. ... company with mobile health and big data solutions, today announced that its ... today. Please check your local TV listings for when The Dr. Oz ... ... ninth season this month. ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
Breaking Medicine Technology: